California Public Employees Retirement System’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $165M | Sell |
|
|||||
|
2025
Q1 | $300M | Buy |
|
|||||
|
2024
Q4 | $259M | Sell |
|
|||||
|
2024
Q3 | $391M | Sell |
|
|||||
|
2024
Q2 | $396M | Sell |
|
|||||
|
2024
Q1 | $392M | Sell |
|
|||||
|
2023
Q4 | $362M | Sell |
|
|||||
|
2023
Q3 | $346M | Sell |
|
|||||
|
2023
Q2 | $401M | Sell |
|
|||||
|
2023
Q1 | $471M | Sell |
|
|||||
|
2022
Q4 | $442M | Sell |
|
|||||
|
2022
Q3 | $512M | Sell |
|
|||||
|
2022
Q2 | $453M | Sell |
|
|||||
|
2022
Q1 | $542M | Sell |
|
|||||
|
2021
Q4 | $495M | Sell |
|
|||||
|
2021
Q3 | $486M | Buy |
|
|||||
|
2021
Q2 | $444M | Buy |
|
|||||
|
2021
Q1 | $375M | Sell |
|
|||||
|
2020
Q4 | $400M | Sell |
|
|||||
|
2020
Q3 | $465M | Sell |
|
|||||
|
2020
Q2 | $523M | Buy |
|
|||||
|
2020
Q1 | $89.8M | Sell |
|
|||||
|
2019
Q4 | $73M | Buy |
|
|||||
|
2019
Q3 | $51M | Buy |
|
|||||
|
2019
Q2 | $41.7M | Sell |
|
|||||
|
2019
Q1 | $58.4M | Sell |
|
|||||
|
2018
Q4 | $54.5M | Sell |
|
|||||
|
2018
Q3 | $66.7M | Sell |
|
|||||
|
2018
Q2 | $61.2M | Sell |
|
|||||
|
2018
Q1 | $64M | Buy |
|
|||||
|
2017
Q4 | $69.5M | Buy |
|
|||||
|
2017
Q3 | $77.8M | Buy |
|
|||||
|
2017
Q2 | $84.8M | Buy |
|
|||||
|
2017
Q1 | $65.7M | Sell |
|
|||||
|
2016
Q4 | $64.7M | Buy |
|
|||||
|
2016
Q3 | $68.3M | Sell |
|
|||||
|
2016
Q2 | $64.8M | Sell |
|
|||||
|
2016
Q1 | $70.9M | Sell |
|
|||||
|
2015
Q4 | $114M | Buy |
|
|||||
|
2015
Q3 | $97.2M | Hold |
|
|||||
|
2015
Q2 | $107M | Buy |
|
|||||
|
2015
Q1 | $80.9M | Hold |
|
|||||
|
2014
Q4 | $80.9M | Sell |
|
|||||
|
2014
Q3 | $74.6M | Buy |
|
|||||
|
2014
Q2 | $56.4M | Sell |
|
|||||
|
2014
Q1 | $63.5M | Sell |
|
|||||
|
2013
Q4 | $65.3M | Buy |
|
|||||
|
2013
Q3 | $59.3M | Buy |
|
|||||
|
2013
Q2 | $41.9M | Buy |
|